# Safety and Efficacy of Smoked Cannabis for Improving Quality of Life in Advanced Cancer Patients

> **NCT03339622** · PHASE3 · TERMINATED · sponsor: **Tetra Bio-Pharma** · enrollment: 8 (actual)

## Conditions studied

- Cancer
- Chronic Pain Due to Malignancy (Finding)

## Interventions

- **COMBINATION_PRODUCT:** PPP001
- **COMBINATION_PRODUCT:** placebo

## Key facts

- **NCT ID:** NCT03339622
- **Lead sponsor:** Tetra Bio-Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-03-29
- **Primary completion:** 2018-12-17
- **Final completion:** 2019-02-08
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Mycotoxin potential contamination of one lot of study drug
- **Last updated:** 2019-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03339622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03339622, "Safety and Efficacy of Smoked Cannabis for Improving Quality of Life in Advanced Cancer Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03339622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*